Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population
Clinical trial NCT02363868 · COMPLETED
Trial details
- NCT number
- NCT02363868
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-11-01
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.